Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2005
06/01/2005CN1621050A Medicine for treating burns and scalds
06/01/2005CN1621049A Medicine for treating burns and scalds
06/01/2005CN1621048A Process for preparing medicine to treat facial acne
06/01/2005CN1621046A Externally applied medicine for treating skin cold injury, swelling and pain, fester and subdermal cyst and its preparation method
06/01/2005CN1621028A Powder for washing feet
06/01/2005CN1621027A Mixed medicinal superfine powder specified for human body private region
06/01/2005CN1621026A Skin caring cream with active Chinese drug component
06/01/2005CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs.
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
06/01/2005CN1203889C Burn treating medicine
06/01/2005CN1203888C Medicine for treating various fungal skin disease or bromidrosis
06/01/2005CN1203882C Medicinal composition for treating wound surface
06/01/2005CN1203874C External-used burn and scald treating medicine and its prepn. process
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203847C Chemically-defined non-polymeric valency plateform molecules and conjugates thereof
05/2005
05/31/2005US6900338 Scavenger compounds
05/31/2005US6900334 Antiallergens; autoimmune diseases
05/31/2005US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor
05/31/2005US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst
05/31/2005US6900243 Phenylheteroalkylamine derivatives
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900027 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
05/31/2005US6899897 Comprises benzoin gum, fungicidal clotrimazole, and ethanol; for treatment of athelete's foot, eczema, seborrheic dermatitis and psoriasis
05/26/2005WO2005046630A1 Hair restorer compositions and antipruritic agent
05/26/2005WO2005046624A1 Cosmetic composition
05/26/2005WO2005046623A1 Combined cosmetic or therapeutic preparation
05/26/2005WO2005027951B1 Method for controlling angiogenesis in animals
05/26/2005WO2005009456A3 Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
05/26/2005WO2005000843A3 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
05/26/2005WO2004072687A8 Method and apparatus for correcting vision using an electro-active phoropter
05/26/2005US20050113773 irradiating a paste mixture of chitin and/or chitosan derivatives, to form hydrogels having antimicrobial activity, used in disposable diapers or as humectants in cosmetics
05/26/2005US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113447 Selective retinoid agonists
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113378 As inhibitors of the retinoic acid-metabolism, as drugs; breast cancer; psoriasis
05/26/2005US20050113377 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase, 2 (COX-2) inhibitors
05/26/2005US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic
05/26/2005US20050113312 2-0-(-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containning compositions comprising it
05/26/2005US20050113299 Protein a compositions and methods of use
05/26/2005US20050113284 Drug for regenerating tissue and vessel and method therefor
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112565 Proteases
05/26/2005US20050112182 Medical adhesive and medical covering agent using ultraviolet ray curable chitosan derivative
05/26/2005US20050112166 Insect repellent compounds
05/26/2005US20050112158 Method for synthesis of silylated ascorbic acid derivatives
05/26/2005US20050112150 Promoting exfoliation; mixture of polypeptide and protease; skin disorders; antitumor agents
05/26/2005US20050112127 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
05/26/2005US20050112110 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators
05/26/2005US20050112079 Administering andothelins, or antagonist thereof, as drug or cosmetics for hair removal or wool harvesting
05/26/2005CA2545841A1 Use of lipopeptides for activating t lymphocytes through the skin
05/26/2005CA2544308A1 Cytokine antagonist molecules
05/26/2005CA2544252A1 Stem cell culture medium and method of using said medium and the cells
05/26/2005CA2543806A1 Combined cosmetic or therapeutic preparation
05/25/2005EP1533313A1 Novel derivative of flavone c-glycoside and composition containing the same
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532974A2 Aqueous gel comprising 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
05/25/2005EP1532242A2 Methods for preparing purified prostaglandin e synthase
05/25/2005EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/25/2005EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3
05/25/2005EP1532144A1 Novel quinuclidine derivatives and their use
05/25/2005EP1532135A1 Nf-kb inhibitors
05/25/2005EP1532133A1 Nf-:b inhibitors
05/25/2005EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid
05/25/2005EP1532102A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof
05/25/2005EP1531857A1 Metalloproteinase inhibitors
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531843A1 Method for treating cervical cancer
05/25/2005EP1531837A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
05/25/2005EP1531834A1 Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders
05/25/2005EP1531833A1 Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders
05/25/2005EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
05/25/2005EP1531818A1 Topical treatment of skin diseases
05/25/2005EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1411908B1 Nitrogen oxide generating compositions for the treatment of subungual infections
05/25/2005EP1365762A4 Method for increasing leptin levels using nicotinic acid compounds
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1161146B1 Deep penetrating antimicrobial compositions
05/25/2005EP1115434B1 Adhesive protein foam for surgical and/or therapeutic uses
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005CN1620510A Cytokine protein family
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620451A Benzhydryl derivatives
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
05/25/2005CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620414A 维生素d类似物 Vitamin d analogues
05/25/2005CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
05/25/2005CN1620308A Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1065